Unknown

Dataset Information

0

The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis.


ABSTRACT: Background:Tuberculosis remains a huge public health problem and the prolonged treatment duration obstructs effective tuberculosis control. Higher rifampicin doses have been associated with better bactericidal activity, but optimal dosing is uncertain. This analysis aimed to characterize the relationship between rifampicin plasma exposure and treatment response over 6 months in a recent study investigating the potential for treatment shortening with high-dose rifampicin. Methods:Data were analyzed from 336 patients with pulmonary tuberculosis (97 with pharmacokinetic data) treated with rifampicin doses of 10, 20, or 35 mg/kg. The response measure was time to stable sputum culture conversion (TSCC). We derived individual exposure metrics with a previously developed population pharmacokinetic model of rifampicin. TSCC was modeled using a parametric time-to-event approach, and a sequential exposure-response analysis was performed. Results:Higher rifampicin exposures increased the probability of early culture conversion. No maximal limit of the effect was detected within the observed range. The expected proportion of patients with stable culture conversion on liquid medium at week 8 was predicted to increase from 39% (95% confidence interval, 37%-41%) to 55% (49%-61%), with the rifampicin area under the curve increasing from 20 to 175 mg/L·h (representative for 10 and 35 mg/kg, respectively). Other predictors of TSCC were baseline bacterial load, proportion of culture results unavailable, and substitution of ethambutol for either moxifloxacin or SQ109. Conclusions:Increasing rifampicin exposure shortened TSCC, and the effect did not plateau, indicating that doses >35 mg/kg could be yet more effective. Optimizing rifampicin dosage while preventing toxicity is a clinical priority.

SUBMITTER: Svensson EM 

PROVIDER: S-EPMC6005123 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis.

Svensson Elin M EM   Svensson Robin J RJ   Te Brake Lindsey H M LHM   Boeree Martin J MJ   Heinrich Norbert N   Konsten Sarah S   Churchyard Gavin G   Dawson Rodney R   Diacon Andreas H AH   Kibiki Gibson S GS   Minja Lilian T LT   Ntingiya Nyanda E NE   Sanne Ian I   Gillespie Stephen H SH   Hoelscher Michael M   Phillips Patrick P J PPJ   Simonsson Ulrika S H USH   Aarnoutse Rob R  

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20180601 1


<h4>Background</h4>Tuberculosis remains a huge public health problem and the prolonged treatment duration obstructs effective tuberculosis control. Higher rifampicin doses have been associated with better bactericidal activity, but optimal dosing is uncertain. This analysis aimed to characterize the relationship between rifampicin plasma exposure and treatment response over 6 months in a recent study investigating the potential for treatment shortening with high-dose rifampicin.<h4>Methods</h4>D  ...[more]

Similar Datasets

| S-EPMC6153781 | biostudies-literature
| S-EPMC6685538 | biostudies-literature
| S-EPMC9387084 | biostudies-literature
| S-EPMC10583668 | biostudies-literature
| S-EPMC10519386 | biostudies-literature
| S-EPMC8555815 | biostudies-literature
| S-EPMC6955640 | biostudies-literature
| S-EPMC10783999 | biostudies-literature
| S-EPMC4821555 | biostudies-literature
| S-EPMC4873565 | biostudies-literature